Mease Philip J
Seattle Rheumatology Associates, Seattle, Washington 98104, USA.
J Rheumatol. 2008 Jul;35(7):1426-30.
A key objective of the assessment working group of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) was to identify, develop, evaluate, and validate outcome measures for use in clinical trials of psoriatic arthritis (PsA) and in clinical practice. In plenary and breakout sessions at the GRAPPA annual meeting (Boston, September 2007), the current status of measures used in clinical trials was reviewed, and development of simplified measures for use in various types of clinical practice (rheumatology, dermatology, and general practice) was discussed. We present a review of those discussions.
银屑病和银屑病关节炎研究与评估小组(GRAPPA)评估工作组的一个关键目标是识别、开发、评估和验证用于银屑病关节炎(PsA)临床试验及临床实践的疗效指标。在GRAPPA年会(2007年9月,波士顿)的全体会议和分组会议上,回顾了临床试验中所使用指标的现状,并讨论了开发适用于各类临床实践(风湿病学、皮肤病学和全科医学)的简化指标。我们在此对这些讨论内容进行综述。